The manufacture of drugs and drug products is one of the most closely regulated activity in the industry. The core of Good Manufacturing Practice is defined and determined by a variety of guidelines and regulations issued and updated regularly by national and international authorities. These have direct implications for the development, manufacturing, and reliable distribution of pharmaceutical parenteral products.
This and more will be the focus of the 2020 PDA Europe Quality and Regulations conference, presented as a virtual conference.
By joining this two-day event, attendees will ensure to receive the most current and thorough information on recent and most important changes in the regulatory landscape.
In the era of breakthrough medicinal therapies and accelerated R&D, Lifecycle and Change Management, Knowledge and Risk Management as well as availability of these drugs become pivotal milestones.
Dive into the new decade with PDA by exploring Digital Solutions in Quality and don’t miss out on learnings on impurity controls and control strategy!
The Conference Chairs
Barbara Allen, PhD, Eli Lilly
Prof. Frank Hallinan, PhD, Consultant